Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|November 15, 2020
Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulationsSourav Pal, Barnali Paul, Purbita Bandopadhyay, et al.Journal of Medicinal Chemistry|August 12, 2022
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural SubunitsNirmal Das, Purbita Bandopadhyay, Swarnali Roy, et al.The Journal of Organic Chemistry|November 21, 2007
Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analoguesWenlan Chen, Chengfeng Xia, Jinhua Wang, et al.Chemmedchem|March 31, 2023
Mitigating hERG Liability of Toll-Like Receptor 9 and 7 Antagonists through Structure-Based DesignNirmal Das, Debomita Bhattacharya, Purbita Bandopadhyay, et al.Bioorganic & Medicinal Chemistry|May 1, 2010
Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthaseArindam Talukdar, Ekaterina Morgunova, Jianxin Duan, et al.Journal of Medicinal Chemistry|March 22, 2019
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer ActivityBiswajit Kundu, Subhendu K Das, Srijita Paul Chowdhuri, et al.European Journal of Medicinal Chemistry|October 8, 2018
Activity-guided development of potent and selective toll-like receptor 9 antagonistsBarnali Paul, Oindrila Rahaman, Swarnali Roy, et al.European Journal of Medicinal Chemistry|August 19, 2023
Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approachDebomita Bhattacharya, Alice Shi Ming Li, Barnali Paul, et al.Journal of Medicinal Chemistry|June 18, 2021
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, et al.Journal of Medicinal Chemistry|May 8, 2024
Exploring the Structural Attributes of Yoda1 for the Development of New-Generation Piezo1 Agonist Yaddle1 as a Vaccine Adjuvant Targeting Optimal T Cell ActivationSunny Goon, Chinky Shiu Chen Liu, Uddipta Ghosh Dastidar, et al.Pageof 4